Rare diseases
Investigational molecules
Locations
Back to Poland51 clinical trials in Bytom, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
PolandStudy of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines
PolandStudy on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus
PolandStudy on the Effects of MORF-057 for Adults with Moderate to Severe Crohn's Disease
PolandPhase 3 Study of Enpatoran in Patients with Active Cutaneous Lupus Erythematosus (with or without Systemic Disease)
PolandLong‑Term Safety and Efficacy of RO7790121 in Adults with Moderate to Severe Rheumatoid Arthritis: Extension Study
PolandNipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus
PolandTulisokibart for Psoriatic Arthritis in Adults
PolandEfficacy of intra‑articular allogeneic peripheral blood mononuclear cells induced to an early apoptotic state versus placebo in adults with primary knee osteoarthritis
PolandEvaluation of Long-Term Safety and Efficacy of Litifilimab in Adults with Active Systemic Lupus Erythematosus: A Phase 3 Multicenter, Randomized, Dose-Blind Study
PolandStudy of icotrokinra for adults with moderately to severely active Crohn's disease
PolandTesting icotrokinra compared to placebo for adults and adolescents with moderately to severely active ulcerative colitis
PolandThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on systemic lupus erythematosus treatments, including studies of innovative therapies like litifilimab and ianalumab. Multiple trials are evaluating new approaches to managing psoriatic arthritis and plaque psoriasis.
Studies aim to improve disease management and patient outcomes through targeted therapies.
Innovative research into inflammatory bowel diseases, with particular focus on Crohn's disease and ulcerative colitis treatments. Studies are evaluating novel compounds like obefazimod and NX-13 for therapeutic efficacy.
Trials emphasize both symptom management and disease modification approaches.
Studies addressing knee osteoarthritis and related conditions, including innovative approaches combining weight management with joint health treatments. Research includes evaluation of new immunotherapy options.
Focus on developing treatments that improve mobility and reduce pain.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
